As per the European Society of Human Reproduction and Embryology (ESHRE) Guideline [167], the diagnostic criteria include: (i) amenorrhea/oligomenorrhea for at least four months, (ii) elevated FSH levels exceeding 25 IU/l on two separate occasions with an interval greater than four weeks. Here, BRD2 is linked to amenorrhea.